These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15196814)

  • 21. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
    Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H
    J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD; Whittaker KM; Choi R; Tashkin DP; Baldwin GC
    J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thy/Liv-SCID-Hu mice implanted with human intestine: an in vivo model for investigation of mucosal transmission of HIV.
    Gibbons C; Kollmann TR; Pettoello-Mantovani M; Kim A; Goldstein H
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1453-60. PubMed ID: 9390744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL; Sanhadji K; Sembeil R
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pivotal role of animal models in the development of new therapies for cytomegalovirus infections.
    Kern ER
    Antiviral Res; 2006 Sep; 71(2-3):164-71. PubMed ID: 16828175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
    Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR
    Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.
    McCune J; Kaneshima H; Krowka J; Namikawa R; Outzen H; Peault B; Rabin L; Shih CC; Yee E; Lieberman M
    Annu Rev Immunol; 1991; 9():399-429. PubMed ID: 1910684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.
    Stevens M; Pollicita M; Pannecouque C; Verbeken E; Tabarrini O; Cecchetti V; Aquaro S; Perno CF; Fravolini A; De Clercq E; Schols D; Balzarini J
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1407-13. PubMed ID: 17242146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
    Kaneshima H; Shih CC; Namikawa R; Rabin L; Outzen H; Machado SG; McCune JM
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4523-7. PubMed ID: 1903543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of HIV infection in AZT-treated SCID-hu mice.
    McCune JM; Namikawa R; Shih CC; Rabin L; Kaneshima H
    Science; 1990 Feb; 247(4942):564-6. PubMed ID: 2300816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
    Alder J; Hui YH; Clement J
    Antiviral Res; 1995 May; 27(1-2):85-97. PubMed ID: 7486961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.